Roberta M. White Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 72 Whetstone Rd, Brattleboro, VT 05301 Phone: 902-275-2682 |
Stephanie Case, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 14 Park Place, Brattleboro, VT 05301 Phone: 802-257-8687 Fax: 802-451-1981 |
John T Moran, MA, LADC Psychologist Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview St, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 |
Jeremy Dixon Birch, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 73 Main St, Brattleboro, VT 05301 Phone: 802-257-9468 |
Ms. Deborah K Titus, MSW LICSW Psychologist Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview Street, Brattleboro, VT 05301 Phone: 802-254-7500 Fax: 802-254-7501 |
Lisa L Nicholson, LICSW Psychologist Medicare: Accepting Medicare Assignments Practice Location: 29 Elm St, Brattleboro, VT 05301 Phone: 802-254-7511 Fax: 802-254-7506 |
Dr. Harvey Liss, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 67 Main St, Suite 38, Brattleboro, VT 05301 Phone: 802-257-1062 Fax: 802-257-4399 |
Carolyn E Fish, M.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 67 Main St, Suite 42, Brattleboro, VT 05301 Phone: 802-257-0146 |
Timothy Rowland, M.D. Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 1 Anna Marsh Lane, Brattleboro, VT 05301 Phone: 802-257-7785 |
Mr. Michael A. Italia, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 139 Main St, Suite 704, Brattleboro, VT 05301 Phone: 802-254-5875 |
Barry P Nelson, PSYCHOLOGIST - MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview St, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 |
Mark Anagnostopulos Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: Anna Marsh Lane, Brattleboro, VT 05302 Phone: 802-257-7785 |
Edward Sbardella, MD Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 75 Linden St, Brattleboro, VT 05301 Phone: 802-257-7785 |
Allen Ross, PHD Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: Anna Marsh Lane, Brattleboro, VT 05302 Phone: 802-257-7785 |
Jessica Tamulonis, PH.D. Psychologist - Counseling Medicare: Medicare Enrolled Practice Location: 1 Anna Marsh Lane, Brattleboro, VT 05302 Phone: 802-275-3165 Fax: 802-258-3743 |
Karen Kamenetzky Psychologist Medicare: Not Enrolled in Medicare Practice Location: 167 Main St, Suite 16, Brattleboro, VT 05301 Phone: 802-254-6038 |
Ms. Teresa Boni, LICSW Psychologist Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview Street, Brattleboro, VT 05301 Phone: 802-254-7500 Fax: 802-254-7501 |
Judith A. Davidson, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 167 Main St, Suite 401, Brattleboro, VT 05301 Phone: 802-257-1660 |
Dr. Martha B. Straus, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 139 Main Street, Brattleboro, VT 05301 Phone: 802-257-4393 Fax: 802-257-9393 |
Susan Balaban Psychologist - Clinical Medicare: May Accept Medicare Assignments Practice Location: 1 Anna Marsh Lane, Brattleboro, VT 05302 Phone: 802-257-7785 Fax: 802-258-3723 |
News Archive
Researchers at the National Institutes of Health (NIH) have devised a four-part small-molecule cocktail that can protect stem cells called induced pluripotent stem cells (iPSCs) from stress and maintain normal stem cell structure and function.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry and Cell Biology entitled, "TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P."
Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological approach, presented clinical research from its trials using its cancer drug BPM 31510 on Phase Ib solid tumors and preclinical data on triple negative breast cancer, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO), May 29 – June 2 in Chicago.
MorphoSys AG today published first safety and efficacy data on its proprietary drug candidate MOR202. The data are from a phase 1/2a study in 42 heavily pretreated patients with relapsed/refractory multiple myeloma.
› Verified 1 days ago